Exela Technologies, Inc. ("Exela"), formed through the strategic combination of SourceHOV and Novitex is a location-agnostic global business process automation ("BPA") leader across numerous industries, combining industry-specific and multi-industry enterprise software and solutions with decades of experience. Our BPA suite of solutions are deployed in banking, healthcare, insurance and other industries to support mission critical environments. Exela is a leader in work flow automation, attended and un-attended cognitive automation, digital mail rooms, print communications, and payment processing with deployments across the globe. Exela partners with customers to improve user experience and quality through operational efficiency. Exela serves over 4,000 customers worldwide, through a secure, cloud-enabled global delivery model.
Exela became a public company on July 13, 2017.
Exela’s common stock is traded on the Nasdaq exchange under the ticker symbol “XELA.” Additionally, Exela has a Series B Preferred Stock that trades under “XELAP.”
Exela’s headquarter are located at 2701 E. Grauwyler Road Irving TX, USA
Exela was formed in 2017 and is incorporated in Delaware.
Exela currently does not have a direct stock purchase plan.
Exela common stock can be purchased on the open market through any registered broker.
Exela’s common stock currently does not pay a dividend. Exela issued Series B Preferred Stock with dividends payable quarterly on XELAP when, as and if declared by the Board of Directors.
All questions regarding ownership of Exela stock should be addressed to the appropriate transfer agent:
Continental Stock Transfer & Trust
1 State Street Plaza, 30th Floor
New York, New York 10004-1561
Tel: (212) 509 4000
The Exela fiscal year will run on a calendar year with quarters ending on March 31, June 30, September 30 and December 31.
Exela’s independent accountants are KPMG.
Please view a full list of Exela’s Board of Directors.
Exela has approximately 17,000 employees
Please fill the email alerts form to receive information about the company.
Please see our IR Contacts page for contact information.
Q: What is STS?
A: Exela created XCV-STS, LLC to “Serve the Shareholders.” STS holds assets that we have set aside to benefit shareholders.
Q: Does STS currently hold any assets?
A: On August 3, 2022, Exela announced that it holds $70 million of face value 2026 notes purchased at a discount.
Q: Who receives the coupon payment that is due on these notes?
A: STS is entitled to receive the coupon. When STS receives the coupon, it may use the coupon for the benefit of the Exela shareholders including but not limited to a dividend or used as part of a share buyback program, subject to applicable laws and relevant approvals.
Q: Will you retire these notes?
A: STS currently plans to continue to hold these notes to maturity. However, it may also sell them earlier for cash, which could then be employed by STS as described above.
Q: What was announced on October 10, 2022?
A: Exela and CF Acquisition Corp. VIII announced the next stage in the public listing of Exela’s European business, called XBP Europe. The press release is listed here, https://investors.exelatech.com/news-releases/news-release-details/exela-technologies-incs-european-business-go-public-through
Q: What will XELA holders receive when the transaction closes?
A: Exela’s subsidiary, the seller, will receive shares of the standalone public company for its shares of XBP Europe. The enterprise value of XBP Europe at today’s valuation is approximately $220 million. XBP Europe currently generates ~$200 million in revenue annually. More details can be found here, http://exelatechnologies.gcs-web.com/static-files/7a68cfc1-fec6-4ba1-a748-becbb83ab336
Q: Who will own the publicly traded entity?
A: Exela will indirectly own the vast majority of the shares in the entity which will be publicly listed on the Nasdaq.
Q: Why are you taking XBP Europe public?
A: We believe that Exela is undervalued and expect this transaction to benefit Exela shareholders to help realize some of the real value of Exela.
Q: When will we learn more about the transaction?
A: We will provide updates as we make progress per guidelines mandated by the SEC.
Q: Will the new combined company have debt?
A: While we don’t have specifics until the close of the transaction. we expect the new combined company to have cash, some debt and working capital lines used for the growth of business.
Q: Will Exela Technologies Inc. receive cash in this transaction?
A: Exela’s subsidiary will receive shares in this transaction and we will provide further plans for these shares as information becomes available.